Oxidant-antioxidant balance in patients with psoriasis

Medical Science Monitor

Volumn 13, Issue 1, 2007, Pages

  Woźniak, Alina ^a   Drewa, Gerard ^a   Krzyzyńska Malinowska, Ewa ^a   Czajkowski, Rafał ^a   Protas Drozd, Franciszka ^a   Mila Kierzenkowska, Celestyna ^a   Rozwodowska, Małgorzata ^a   Sopońska, Małgorzata ^a   Czarnecka Zaba, Ewa ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Antioxidant enzymes; Lipid peroxidation; Malondialdehyde; Psoriasis

Indexed keywords

ANTIOXIDANT; BETAMETHASONE DIPROPIONATE; DITHRANOL; GLUTATHIONE PEROXIDASE; OXIDIZING AGENT; SALICYLIC ACID; TAR; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PSORIASIS;

ADULT; ANTIOXIDANTS; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; OXIDANTS; PSORIASIS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33845984549     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sztaba-Kania M, Placek W: Circulatory immune complexes in the sera of psoriatics. Przegl Dermatol, 1986; 1: 12-17
2. Rotsztejn H, Zalewska A, Trznadel-Budźko E et al.: Influence of systemic photochemotherapy on regulatory T cells and selected cytokine production in psoriatic patients: a pilot study. Med Sci Monit, 2005; 11: CR594-98
3. Namazi MR: Steroid sulfatase inhibitors as novel additions to the antipsoriatic armamentarium. Med Sci Monit, 2005; 11(3): HY7-9
4. Schön MP, Boehncke WH: Psoriasis. NEJM, 2005; 352(18): 1899-912
5. Teranishi Y, Mizutani H, Murata M et al: Increased spontaneous production of IL-8 in peripheral blood monocytes from the psoriatic patient: relation to focal infection and response to treatments. J Dermatol Sci, 1995; 10: 8-15
6. Naldi L, Parazzini F, Peli L et al: Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol, 1996; 134: 101-6
7. Dubertret L. Psoriasis: evolution and revolution. Med Sci (Paris), 2006; 22(2): 164-71
8. Kaszuba A: Oxide metabolism of neutrophils and blood sera in psoriatics treated with combined methods. Przegl Dermatol, 1993; 80: 140-51
9. Drewa G, Gwieździński Z, Krzyzyńska-Malinowska E et al.: Activity of acid phosphatase and cathepsin D in blood serum of patients with psoriasis before and after therapy-preliminary study. Med Sci Monit, 1999; 5(4): 656-60
10. Das UN: Is angiotensin-II an endogenous pro-inflammatory molecule? Med Sci Monit, 2005; 11(5): RA155-62
11. Briganti S, Picardo M: Antioxidant activity, lipid peroxidation and skin diseases. What's new. JEADV, 2003; 17: 663-69
12. Woźniak A, Drewa T, Woźniak B et al: The role of free oxide radicals in the appearance of tumor metastases. Onkol Pol, 2001; 4(3-4): 135-39
13. Brigelius-Flohe R: Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med, 1999; 27: 951-65
14. Waszczykowska E, Sysa-Jȩdrzejowska A, Błaszczyk J et al: The contribution of reactive oxygen species in the etiopathogenesis of systemic lupus erythematosus. Przegl Dermatol, 1997; 84: 517-23
15. Drewa G, Krzyzyńska-Malinowska E, Woźniak A et al: Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis. Med Sci Monit, 2002; 8: BR338-43
16. Giulivi C, Hochstein P, Davies KJA: Hydrogen peroxide production by red blood cells. Free Radic Biol Med, 1994; 16: 123-29
17. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase J Lab Clin, 1967; 70: 158-68
18. Buege JA, Aust SD: Microsomal lipid peroxidation. In: Fleisher S, Packer I (eds.) Methods in enzymology. New York: Academic Press, 1978; 302-10
19. Pershing LK, Lambert L, Wright ED et al: Topical 0.050% betamethasone dipropionate. Pharmacokinetic and pharmacodynamic dose-response studies in humans.Arch Dermatol, 1994; 130(6): 740-47
20. Robert C, Kupper TS: Inflammatory skin diseases, T cells, immune surveillance. N Engl J Med, 1999; 341: 1817-28
21. Ramsing DW, Agner T: Efficacy of topical corticosteroids on irritant skin reactions. Contact Dermatitis, 1995; 32(5): 293-97
22. Gavan N, Maibach H: Effect of topical corticosteroids on the activity of superoxide dismutase in human skin in vitro: Skin Pharmacol, 1997; 10: 309-13
23. Therond P, Gerbaud P, Dimon S et al: Antioxidant enzymes in psoriatic fibroblasts and erythrocytes. J Invest Dermatol, 1996; 106: 1325-28
24. Schena D, Chieregato GC, de Gironcoli M et al: Increased erythrocyte membrane arachidonate and platelet malondialdehyde (MDA) production in psoriasis: normalization after fish-oil. Acta Derm Venereol Suppl (Stockh), 1989; 146: 42-44
25. Kaszuba A: Glutathione peroxidase activity and malondialdehyde level in erythrocytes during the course of psoriasis. Przegl Dermatol, 1993: 80: 24-32
26. Kopff M, Zakrzewska I, Strzelczyk M et al: Superoxide dismutase and catalase activity in psoriatic patients treated topically with ointment containing 2-chloroethyl-3-chloropropyl sulfide. Pol J Pharmacol, 1994; 46: 439-44
27. Kaszuba A, Błaszczyk J, Ruszczak Z et al: The generation of superoxide free radicals by peripheral blood leukocytes in psoriatics treated with Re-PUVA-C. Przegl Dermatol, 1990; 77: 307-12
28. Allen DL, Cierzan JJ: Relative susceptibility of lipids to peroxidation in intact erythrocytes. J Lab Clin Med, 1988; 112: 87-91
29. Dogan P, Souer U, Tenriculu G: Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leucocytes and serum ceruloplasmin and copper levels in psoriasis. Br J Dermatol, 1989; 120: 239-44
30. Popov I, Muller GM, Miehe M et al: The relationship between the antioxidant potential of psoriatic blood plasma and granulocyte reactivity. Dermatol Monatsschr, 1990; 176: 43-48
31. Offidani AM, Ferretti G, Taus M et al: Lipoprotein peroxidation in adult psoriatic patients. Acta Derm Venerol Suppl (Stockh), 1994; 186: 38-40
32. Baz K, Cimen MYB, Kokturk A et al: Oxidant/antioxidant status in patients with psoriasis. Yonsei Med J, 2003; 44(6): 987-90